PREVENTION OF THE RISKS ASSOCIATED WITH DRUG-INDUCED QT INTERVAL PROLONGATION BY USING A SPECIFIC INHIBITOR OF THE PRODUCTION OF ROS OF MITOCHONDRIAL ORIGIN

摘要

The present invention concerns the prevention and/or treatment of diseases in which reactive oxygen species (or ROS) of mitochondrial origin are involved. More particularly, it concerns the use of an inhibitor of mitochondrial ROS production, in particular anethole trithione, for preventing the risks associated with QT prolongation when taking drugs known to induce such a secondary effect.